Feld JJ, Wahed AS, Fried M, Ghany MG, et al. Withdrawal of long-term nucleotide analogue therapy in chronic hepatitis B: Outcomes from the withdrawal phase of the HBRN immune active treatment trial. Am J Gastroenterol 2023 Jan 13. doi: 10.14309/ajg.0000000000002176.
PMID: 36728214